GAM
BLUE

Gotham Asset Management’s bluebird bio BLUE Stock Holding History

Gotham Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-578
Closed -$79.9K – 1324
2022
Q4 		$79.9K Buy
+578
New +$81.4K ﹤0.01% 1184
2018
Q4 		– Sell
-376
Closed -$710K – 986
2018
Q3 		$710K Sell
376
-83
-18% -$171K 0.01% 674
2018
Q2 		$932K Sell
459
-86
-16% -$196K 0.01% 603
2018
Q1 		$1.2M Sell
545
-3
-0.5% -$7.63K 0.02% 581
2017
Q4 		$1.26M Sell
548
-4,049
-88% -$8.22M 0.02% 554
2017
Q3 		$8.18M Buy
4,597
+3,618
+370% +$5.05M 0.12% 268
2017
Q2 		$1.33M Buy
+979
New +$1.18M 0.02% 593

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Gotham Asset Management's BLUE Position: Q1 2023 in Review

Gotham Asset Management sold out of bluebird bio (BLUE) in Q1 2023, closing a stake of 578 shares — an estimated $79.9K sold.

Gotham Asset Management first reported a position in BLUE in Q2 2017 and held it in 7 quarters. The position peaked at $8.18M in Q3 2017. 177 funds tracked by Wall St. Rank hold BLUE as of Q1 2023.

  • Gotham Asset Management reported no remaining bluebird bio position as of Q1 2023 after selling out during the quarter.
  • Gotham Asset Management sold 578 bluebird bio shares in Q1 2023, an estimated $79.9K.
  • Gotham Asset Management first reported a position in bluebird bio in Q2 2017 and held it in 7 quarters.
  • Gotham Asset Management's bluebird bio position peaked at $8.18M in Q3 2017.
  • 177 funds tracked by Wall St. Rank held bluebird bio as of Q1 2023.

Based on Gotham Asset Management's 13F filing for Q1 2023, filed 15 May 2023.